What Can You Do With a Master’s in Cell and Gene Therapies?

Cell and gene therapies are reshaping modern medicine. Over the past decade, advances in genetics, immunology, and molecular biology have made it possible to treat diseases in ways that were once unimaginable—from engineering immune cells to fight cancer to correcting faulty genes responsible for inherited disorders.

As the field grows, so does demand for professionals who understand both the science and the regulatory environment behind these therapies. As such, many graduate programs are designed to help students build that foundation through specialized, industry-aligned training.

So, what can you actually do with a master’s in cell and gene therapies?

The answer is broader than many people expect. Graduates work in research labs, biotech manufacturing facilities, regulatory agencies, clinical trial teams, and global health organizations. Some go on to pursue PhDs or MD/PhD programs. Others step directly into industry roles, developing the next generation of therapies.

Below is a closer look at the field and the career paths this degree can open, how it can prepare graduates to take advantage of future opportunities, and how programs such as Northeastern University’s MS in Cell and Gene Therapies are designed with the future in mind.

What is cell and gene therapy?

Cell and gene therapies are a class of treatments that modify or use living cells and genetic material to treat disease.

According to the U.S. Food and Drug Administration, human gene therapy involves manipulating genetic material to modify the expression of a gene or alter the biological properties of living cells for therapeutic use.

In practical terms, these therapies aim to address disease at its biological root by targeting the underlying genetic or cellular mechanisms that cause the condition.

Examples include:

• Gene editing technologies, like CRISPR-Cas9 that modify DNA, via viral or non viral vectors
• Immunotherapy including CAR-T cell therapies, which engineer immune cells to attack cancer
• Cell therapies including stem cell therapy used to regenerate damaged tissues

Unlike traditional pharmaceuticals, which often treat symptoms, cell and gene therapies aim to repair or replace the underlying biological cause of disease.

As Sahar Tavakoli, director of the MS in Cell and Gene Therapies program at Northeastern University, explains, the scientific potential of these therapies continues to expand as researchers develop new approaches.

“There is not only one strategy or approach to use cell and gene therapy to treat disease,” says Tavakoli.

That’s one reason scientists often refer to the field as a new frontier of medicine. Researchers continue to discover new strategies and combinations of technologies that may expand treatment possibilities across cancer, genetic disorders, autoimmune conditions, and rare diseases.

Careers in biotech and biopharma

For many graduates, the most common destination is the biotechnology or biopharmaceutical industry.

According to Tavakoli, many students pursue roles in biotech or biopharma companies after graduation, working in areas such as research, development, manufacturing, and clinical operations.

Salaries in these fields vary depending on specialization and experience. According to the U.S. Bureau of Labor Statistics, professionals working in life sciences roles commonly associated with cell and gene therapy earn strong median wages. For example, medical scientists earn a median annual salary of $100,590, and biochemists and biophysicists earn $103,650.

These roles span multiple functions within biotech companies—from discovery research to manufacturing and clinical development.

Within the biotech/biopharma industry, graduates often pursue careers in three broad areas.

Research and development (R&D) roles

R&D teams are responsible for discovering and designing new therapies. Scientists in these roles investigate biological pathways, engineer cell lines, design viral vectors, and test new therapeutic approaches in laboratory settings.

Typical roles include:

• Cell therapy scientist
• Gene therapy research associate
• Immunotherapy researcher
• Translational research scientist
• Analytical development scientist

These roles often involve collaboration across disciplines—combining molecular biology, genetics, computational analysis, and clinical research.

Process development and manufacturing

Once a therapy shows promise, the next challenge is scaling production. Manufacturing cell and gene therapies requires specialized expertise in areas such as:

• Cell culture systems
• Bioprocess engineering
• Viral vector production
• Quality control testing
• Good manufacturing practice (GMP) compliance

Professionals in these roles ensure that therapies can be produced safely and consistently for clinical trials and commercial use.

Examples of job titles include:

• Bioprocess development scientist
• Manufacturing associate (cell therapy)
• Process development engineer
• Quality assurance specialist

Because advanced therapies involve living cells, the manufacturing process itself often becomes one of the most technically complex parts of the therapy’s development.

Clinical and translational roles

Bringing therapies from the laboratory to patients requires extensive clinical testing. Clinical and translational professionals help manage this process, overseeing clinical trials, patient safety protocols, and regulatory documentation.

Typical roles include:

• Clinical research associate
• Clinical operations manager
• Translational medicine scientist
• Medical affairs specialist

Graduates may work for biotechnology companies, pharmaceutical firms, research hospitals, or contract research organizations.

Regulatory affairs and policy careers

Regulation plays a central role in cell and gene therapy. Because these therapies involve genetic material and living cells, regulatory agencies must carefully evaluate their safety, manufacturing process, and clinical outcomes before approving them for patient use.

This creates significant demand for professionals who understand both science and regulatory frameworks.

Possible career paths include:

• Regulatory affairs specialist
• Clinical regulatory strategist
• Quality systems manager
• Policy advisor for biotechnology regulation
• Regulatory consultant

Professionals in this area work with agencies such as:

• U.S. Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• Global regulatory bodies overseeing advanced therapies

Tavakoli notes that regulatory knowledge is an essential component of training in this field and, as a result, students in Northeastern’s program study the regulatory landscape of cell and gene therapies as part of their coursework, helping them understand how policies evolve internationally and how therapies move through approval pipelines.

Is this degree good preparation for a PhD or MD/PhD?

Not every graduate goes directly from study into industry. Some use a master’s degree as a stepping stone toward advanced academic training.

Students who pursue a PhD or MD/PhD after earning their master’s often benefit from:

• Graduate-level coursework in genetics and immunology
• Laboratory research experience
• Exposure to clinical applications of gene therapy

According to Tavakoli, 10% to 20% of graduates choose to pursue advanced academic degrees. For those students, she explains, a PhD or MD/PhD can be a natural next step because the program gives them research exposure, specialized training in cell and gene therapy, and a clearer sense of whether they want to continue in academic research. In some cases, that preparation may also help students transition more quickly into doctoral study.

Global career opportunities in cell and gene therapy

Cell and gene therapy is a global field. New treatments are being developed in research hubs across North America, Europe, and Asia, while regulatory frameworks continue to evolve worldwide.

As a result, professionals in this space may work in international roles involving:

• Global regulatory strategy
• International clinical trial coordination
• Technology transfer across research institutions
• Health policy and global access initiatives

Tavakoli explains that graduates are trained with a global perspective in mind, with the program touching on different regulations found across different countries, so that “whether they work in the U.S. or somewhere else in the world,” they have the knowledge to contribute to the field.

The human impact: Why this field matters

While the science behind cell and gene therapies is complex, the motivation driving the field is simple: improving patient outcomes.

In some cases, these therapies can treat diseases that previously had few or no treatment options.

Researchers have already documented remarkable cases where advanced therapies have dramatically changed patients’ lives. Tavakoli provides one example involving a newborn who received gene therapy treatment just days after birth, responded positively, and is now “rescued from a genetic disorder.”

Stories like these illustrate why so many scientists and clinicians are drawn to the field.

The potential applications continue to expand—from cancer immunotherapies to treatments for rare inherited conditions and autoimmune diseases.

For professionals entering the field, the work can involve both scientific discovery and tangible patient impact.

Why Northeastern’s cell and gene therapy program stands out

Programs that prepare students for this field typically combine scientific training with real-world experience.

At Northeastern University, the MS in Cell and Gene Therapies program—which offers the flexibility to take courses online or on campus—integrates laboratory coursework, regulatory education, and industry collaboration.

Mandatory co-op experience

One distinctive feature is the three- to six-month graduate co-op placement, where students gain professional experience in biotech companies, research institutions, or government organizations.

These placements allow students to apply classroom knowledge in real research or manufacturing environments before graduating.

Industry-aligned curriculum

The curriculum is designed to reflect evolving industry needs, with input from industry advisors who help shape course topics and training priorities.

Students begin with foundational coursework before moving into specialized topics such as:

• Stem cells and regeneration
• Immunology
• Applied bioinformatics
• Ethics in biological research
• Regulatory landscape of cell and gene therapies

Laboratory and clinical insight

Students also participate in laboratory courses focused on techniques used in cell and gene therapy research, helping them develop hands-on technical skills.

Faculty and guest lecturers often bring experience from clinical and research institutions, including hospitals and biomedical companies, providing real-world context for the science students are learning.

Strong career outcomes

According to Northeastern’s College of Science, 95% of graduates secure employment opportunities soon after completing the program, based on graduate survey data.

A career at the cutting edge of medicine

Cell and gene therapy sits at the intersection of multiple scientific revolutions: genetics, immunology, computational biology, and regenerative medicine.

For graduates entering the field today, the opportunities span research labs, biotech manufacturing facilities, regulatory agencies, and international policy organizations.

The work can be technically challenging—but also deeply meaningful.

As therapies continue to move from clinical trials into real-world use, the demand for professionals who understand both the science and the systems behind these treatments will only grow.

If you’re interested in exploring the field further, you can learn more about Northeastern’s MS in Cell and Gene Therapies program.